Cargando…

Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays

Allogeneic hematopoietic stem cell transplantation (HSCT) recipients frequently develop acute respiratory failure (ARF) with pulmonary infiltrates. Molecular- and biomarker-based assays enhance pathogen detection, but data on their yield in this population are scarce. This was a retrospective single...

Descripción completa

Detalles Bibliográficos
Autores principales: Wohlfarth, Philipp, Turki, Amin T., Steinmann, Joerg, Fiedler, Melanie, Steckel, Nina K., Beelen, Dietrich W., Liebregts, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Blood and Marrow Transplantation. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110883/
https://www.ncbi.nlm.nih.gov/pubmed/29550627
http://dx.doi.org/10.1016/j.bbmt.2018.03.007
_version_ 1783513160383201280
author Wohlfarth, Philipp
Turki, Amin T.
Steinmann, Joerg
Fiedler, Melanie
Steckel, Nina K.
Beelen, Dietrich W.
Liebregts, Tobias
author_facet Wohlfarth, Philipp
Turki, Amin T.
Steinmann, Joerg
Fiedler, Melanie
Steckel, Nina K.
Beelen, Dietrich W.
Liebregts, Tobias
author_sort Wohlfarth, Philipp
collection PubMed
description Allogeneic hematopoietic stem cell transplantation (HSCT) recipients frequently develop acute respiratory failure (ARF) with pulmonary infiltrates. Molecular- and biomarker-based assays enhance pathogen detection, but data on their yield in this population are scarce. This was a retrospective single-center study of 156 consecutive HSCT recipients admitted to the intensive care unit (ICU) between May 2013 and July 2017. Findings from a microbiologic diagnostic workup using currently available methods on bronchoalveolar lavage (BAL) and blood samples from 66 patients (age, 58 years [range, 45 to 64]; HSCT to ICU, 176 days [range, 85 to 407]) with ARF and pulmonary infiltrates were analyzed. In 47 patients (71%) a causative pathogen was identified (fungal, n = 28; viral, n = 26; bacterial, n = 18). Polymicrobial findings involving several pathogen groups occurred in 20 patients (30%). Culture (12/16, 75%), galactomannan (13/15, 87%), and Aspergillus-PCR (8/9, 89%) from BAL but not serum galactomannan (6/14, 43%) helped to diagnose invasive aspergillosis (n = 16, 24%). Aspergillus-PCR detected azole resistance in 2 cases. Mucorales was found in 7 patients (11%; BAL culture, n = 6; Mucorales-PCR, n = 1). Patients with identified pathogens had higher Simplified Acute Physiology Score II scores (P = .049) and inferior ICU survival (6% versus 37%, P < .01), which largely related to the presence of an invasive fungal infection. Eight patients (12%) had 1 or more viruses with uncertain lung pathogenicity as the sole microbiologic finding. A diagnostic microbiologic workup incorporating molecular- and biomarker-based assays identified pathogens in most HSCT recipients with ARF and pulmonary infiltrates admitted to the ICU. Implications of polymicrobial infection and pathogen patterns in these patients warrant further investigation.
format Online
Article
Text
id pubmed-7110883
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Society for Blood and Marrow Transplantation.
record_format MEDLINE/PubMed
spelling pubmed-71108832020-04-02 Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays Wohlfarth, Philipp Turki, Amin T. Steinmann, Joerg Fiedler, Melanie Steckel, Nina K. Beelen, Dietrich W. Liebregts, Tobias Biol Blood Marrow Transplant Article Allogeneic hematopoietic stem cell transplantation (HSCT) recipients frequently develop acute respiratory failure (ARF) with pulmonary infiltrates. Molecular- and biomarker-based assays enhance pathogen detection, but data on their yield in this population are scarce. This was a retrospective single-center study of 156 consecutive HSCT recipients admitted to the intensive care unit (ICU) between May 2013 and July 2017. Findings from a microbiologic diagnostic workup using currently available methods on bronchoalveolar lavage (BAL) and blood samples from 66 patients (age, 58 years [range, 45 to 64]; HSCT to ICU, 176 days [range, 85 to 407]) with ARF and pulmonary infiltrates were analyzed. In 47 patients (71%) a causative pathogen was identified (fungal, n = 28; viral, n = 26; bacterial, n = 18). Polymicrobial findings involving several pathogen groups occurred in 20 patients (30%). Culture (12/16, 75%), galactomannan (13/15, 87%), and Aspergillus-PCR (8/9, 89%) from BAL but not serum galactomannan (6/14, 43%) helped to diagnose invasive aspergillosis (n = 16, 24%). Aspergillus-PCR detected azole resistance in 2 cases. Mucorales was found in 7 patients (11%; BAL culture, n = 6; Mucorales-PCR, n = 1). Patients with identified pathogens had higher Simplified Acute Physiology Score II scores (P = .049) and inferior ICU survival (6% versus 37%, P < .01), which largely related to the presence of an invasive fungal infection. Eight patients (12%) had 1 or more viruses with uncertain lung pathogenicity as the sole microbiologic finding. A diagnostic microbiologic workup incorporating molecular- and biomarker-based assays identified pathogens in most HSCT recipients with ARF and pulmonary infiltrates admitted to the ICU. Implications of polymicrobial infection and pathogen patterns in these patients warrant further investigation. American Society for Blood and Marrow Transplantation. 2018-08 2018-03-14 /pmc/articles/PMC7110883/ /pubmed/29550627 http://dx.doi.org/10.1016/j.bbmt.2018.03.007 Text en © 2018 American Society for Blood and Marrow Transplantation. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Wohlfarth, Philipp
Turki, Amin T.
Steinmann, Joerg
Fiedler, Melanie
Steckel, Nina K.
Beelen, Dietrich W.
Liebregts, Tobias
Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays
title Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays
title_full Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays
title_fullStr Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays
title_full_unstemmed Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays
title_short Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays
title_sort microbiologic diagnostic workup of acute respiratory failure with pulmonary infiltrates after allogeneic hematopoietic stem cell transplantation: findings in the era of molecular- and biomarker-based assays
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110883/
https://www.ncbi.nlm.nih.gov/pubmed/29550627
http://dx.doi.org/10.1016/j.bbmt.2018.03.007
work_keys_str_mv AT wohlfarthphilipp microbiologicdiagnosticworkupofacuterespiratoryfailurewithpulmonaryinfiltratesafterallogeneichematopoieticstemcelltransplantationfindingsintheeraofmolecularandbiomarkerbasedassays
AT turkiamint microbiologicdiagnosticworkupofacuterespiratoryfailurewithpulmonaryinfiltratesafterallogeneichematopoieticstemcelltransplantationfindingsintheeraofmolecularandbiomarkerbasedassays
AT steinmannjoerg microbiologicdiagnosticworkupofacuterespiratoryfailurewithpulmonaryinfiltratesafterallogeneichematopoieticstemcelltransplantationfindingsintheeraofmolecularandbiomarkerbasedassays
AT fiedlermelanie microbiologicdiagnosticworkupofacuterespiratoryfailurewithpulmonaryinfiltratesafterallogeneichematopoieticstemcelltransplantationfindingsintheeraofmolecularandbiomarkerbasedassays
AT steckelninak microbiologicdiagnosticworkupofacuterespiratoryfailurewithpulmonaryinfiltratesafterallogeneichematopoieticstemcelltransplantationfindingsintheeraofmolecularandbiomarkerbasedassays
AT beelendietrichw microbiologicdiagnosticworkupofacuterespiratoryfailurewithpulmonaryinfiltratesafterallogeneichematopoieticstemcelltransplantationfindingsintheeraofmolecularandbiomarkerbasedassays
AT liebregtstobias microbiologicdiagnosticworkupofacuterespiratoryfailurewithpulmonaryinfiltratesafterallogeneichematopoieticstemcelltransplantationfindingsintheeraofmolecularandbiomarkerbasedassays